While Amazon, Berkshire Hathaway and JPMorgan’s effort to provide healthcare themselves looks positive, it will likely only benefit its employees and could raise costs for everyone else, holds Elisabeth Rosenthal of The New York Times. They can negotiate with drug companies to get the best possible deals, which Medicare can’t. This will result in providers raising prices for the latter to make up for losses. The new project seems appealing to those it covers, but there's no guarantee that it will better American healthcare. These companies ultimately serve shareholders.